GSH Response


GSH response copolymers have gained significant attention in the field of drug delivery due to their ability to selectively release drugs in GSH-rich environments, such as tumor cells. This targeted drug delivery approach holds the potential to enhance the therapeutic efficacy of anticancer drugs while minimizing their systemic toxicity. When the GSH response copolymer reaches the target tissue or cell, which is often characterized by higher GSH levels compared to healthy tissue, the presence of GSH triggers the cleavage or disassembly of the copolymer structure. This cleavage event can lead to the release of the encapsulated drug or detachment of the drug from the copolymer backbone, thereby achieving site-specific drug delivery.

CD Bioparticles’ services with customized delivery strategies, precise designs and modifications of drugs or drug-contained cargos, and advanced technical platforms can help you to solve:

The challenges you might meet:

  • Drug degradation or premature release
  • The toxicity of therapeutic drugs can cause damage to normal cells
  • The concentration of the drug at the tumor site is low
  • Tedious copolymers formulation, purifications, and production

Key benefits:

  • Sensitivity to GSH concentration: they have the ability to undergo structural changes or exhibit specific behaviors in response to changes in GSH concentration
  • They allow for targeted drug release at the desired site
  • Good stability and biocompatibility
  • GSH response copolymers can exhibit changes in their physical or chemical properties in response to changes in the GSH concentration in their surrounding environment including changes in solubility, shape, mechanical properties, or surface charge
  • Design flexibility: to be tailored by adjusting the composition, molecular weight, and architecture of the copolymer
  • Suitable for in vitro and in vivo experiments
  • Ready-to-use

Application candidates:

  • Tissue Engineering Scaffolds: by incorporating these copolymers into scaffolds or hydrogels, they can respond to variations in GSH concentration in the local microenvironment, mimicking the natural ECM (extracellular matrix) environment. This can influence cell behavior, including adhesion, migration, proliferation, and differentiation, leading to improved tissue regeneration
  • Drug delivery: they can be designed to respond to the elevated levels of GSH found in specific disease states, such as cancer
  • Biomedical Imaging: they can be incorporated into imaging probes and contrast agents
  • Biosensors: used to develop biosensors for detecting GSH levels
  • Used to monitor GSH levels in environmental samples or to detect GSH-related contaminants or contaminants

Amino-SS-PEG-acid

Catalog: PHRC424

MW: N/A

Biotin-PEG-SS-Alkyne

Catalog: PHRC420

MW: N/A

Biotin-PEG-SS-azide

Catalog: PHRC422

MW: N/A

Biotin-PEG-SS-DBCO

Catalog: PHRC418

MW: N/A

biotin-PEG-SS-NHS

Catalog: PHRC330

MW: N/A

Chitosan - SS - Hyaluronate

Catalog: PHRC381

MW: N/A

Chitosan-SS-cRGD

Catalog: PHRC432

MW: N/A

Chitosan-SS-DOX

Catalog: PHRC434

MW: N/A

Chitosan-SS-DSPE

Catalog: PHRC436

MW: N/A

Chitosan-SS-FITC chitosan

Catalog: PHRC439

MW: N/A

Chitosan-SS-GAL

Catalog: PHRC379

MW: N/A

Chitosan-SS-Mannose

Catalog: PHRC383

MW: N/A

chitosan-SS-octylamine

Catalog: PHRC394

MW: N/A

CPT-SS-DOX

Catalog: PHRC385

MW: N/A

Dex-g-SS-PZLLDex-SS-PCL-PLL

Catalog: PHRC388

MW: N/A

DSPE-PEG-SS-COOH

Catalog: PHRC289

MW: N/A

DSPE-PEG-ss31 peptide

Catalog: PHRC291

MW: N/A

DSPE-SS-PEG-Alkyne

Catalog: PHRC426

MW: N/A

DSPE-SS-PEG-Biotin

Catalog: PHRC293

MW: N/A

DSPE-SS-PEG-DBCO

Catalog: PHRC290

MW: N/A

Products
Fill out the form below
to receive a quote

GET A QUOTE

  • (USA)
  • (Europe)
Copyright © 2024 CD Bioparticles. All rights reserved.
0
Inquiry Basket
Inquiry